Advanced Oncotherapy PLC (LON:AVO) Insider Acquires £18,000 in Stock

Advanced Oncotherapy PLC (LON:AVO) insider Enrico Cipro Vanni bought 100,000 shares of the stock in a transaction on Monday, July 31st. The shares were acquired at an average price of GBX 18 ($0.23) per share, with a total value of £18,000 ($23,367.52).

Advanced Oncotherapy PLC (AVO) opened at 18.00 on Friday. The stock’s 50 day moving average is GBX 15.24 and its 200 day moving average is GBX 29.71. The company’s market cap is GBX 13.04 million. Advanced Oncotherapy PLC has a 52-week low of GBX 9.75 and a 52-week high of GBX 130.00.

COPYRIGHT VIOLATION WARNING: This story was first posted by BNB Daily and is the property of of BNB Daily. If you are reading this story on another site, it was illegally copied and reposted in violation of United States and international trademark & copyright legislation. The original version of this story can be accessed at

Advanced Oncotherapy PLC Company Profile

Advanced Oncotherapy Plc is focused on providing radiotherapy systems for cancer treatment through the use of a proton therapy technology. The Company is engaged in development and then building of the Linac Image Guided Hadron Technology (LIGHT) proton beam cancer therapy device and management of healthcare related property.

Insider Buying and Selling by Quarter for Advanced Oncotherapy PLC (LON:AVO)

Receive News & Ratings for Advanced Oncotherapy PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Oncotherapy PLC and related companies with's FREE daily email newsletter.

Latest News

Leave a Reply